Cargando…
Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009)
BACKGROUND: Multidrug resistant Pseudomonas aeruginosa and Acinetobacter baumannii are common causes of health care associated infections worldwide. Carbapenems are effective against infections caused by multidrug resistant Gram-negative bacteria including Pseudomonas and Acinetobacter species. Howe...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978656/ https://www.ncbi.nlm.nih.gov/pubmed/27547682 http://dx.doi.org/10.1186/s40064-016-2986-7 |
_version_ | 1782447201476149248 |
---|---|
author | Kateete, David P. Nakanjako, Ritah Namugenyi, Juliet Erume, Joseph Joloba, Moses L. Najjuka, Christine F. |
author_facet | Kateete, David P. Nakanjako, Ritah Namugenyi, Juliet Erume, Joseph Joloba, Moses L. Najjuka, Christine F. |
author_sort | Kateete, David P. |
collection | PubMed |
description | BACKGROUND: Multidrug resistant Pseudomonas aeruginosa and Acinetobacter baumannii are common causes of health care associated infections worldwide. Carbapenems are effective against infections caused by multidrug resistant Gram-negative bacteria including Pseudomonas and Acinetobacter species. However, their use is threatened by the emergence of carbapenemase-producing strains. The aim of this study was to determine the prevalence of carbapenem-resistant P. aeruginosa and A. baumannii at Mulago Hospital in Kampala Uganda, and to establish whether the hospital environment harbors carbapenem-resistant Gram-negative rods. RESULTS: Between February 2007 and September 2009, a total of 869 clinical specimens were processed for culture and sensitivity testing yielding 42 (5 %) P. aeruginosa and 29 (3 %) A. baumannii isolates, of which 24 % (10/42) P. aeruginosa and 31 % (9/29) A. baumannii were carbapenem-resistant. Additionally, 80 samples from the hospital environment were randomly collected and similarly processed yielding 58 % (46/80) P. aeruginosa and 14 % (11/80) A. baumannii, of which 33 % (15/46) P. aeruginosa and 55 % (6/11) A. baumannii were carbapenem-resistant. The total number of isolates studied was 128. Carbapenemase genes detected were bla(IMP)-like (36 %, 9/25), bla(VIM)-like (32 %, 8/25), bla(SPM)-like (16 %, 4/25); bla(NDM-1)-like (4 %, 1/25) in carbapenem-resistant P. aeruginosa, and bla(OXA-23)-like (60 %, 9/15), bla(OXA-24)-like (7 %, 1/15), bla(OXA-58)-like (13 %, 2/15), and bla(VIM)-like (13 %, 2/15) in carbapenem-resistant A. baumannii. Furthermore, class 1 integrons were detected in 38 % (48/128) of P. aeruginosa and Acinetobacter, 37 % (26/71) of which were in clinical isolates and 39 % (22/57) in environment isolates. Gene cassettes were found in 25 % (12/48) of integron-positive isolates. These were aminoglycoside adenylyltransferase ant(4′)-IIb (3 isolates); trimethoprim-resistant dihydrofolate reductase dfrA (2 isolates); adenyltransferase aadAB (3 isolates); QacE delta1 multidrug exporter (2 isolates); quinolone resistance pentapeptide repeat protein qnr (1 isolate); and metallo-β-lactamase genes bla(VIM-4)-like, bla(IMP-19)-like, and bla(IMP-26)-like (1 isolate each). Gene cassettes were missing in 75 % (36/48) of the integron-positive isolates. CONCLUSIONS: The prevalence of carbapenem-resistant P. aeruginosa and Acinetobacter among hospitalized patients at Mulago Hospital is low compared to rates from South-East Asia. However, it is high among isolates and in the environment, which is of concern given that the hospital environment is a potential source of infection for hospitalized patients and health care workers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40064-016-2986-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4978656 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-49786562016-08-19 Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009) Kateete, David P. Nakanjako, Ritah Namugenyi, Juliet Erume, Joseph Joloba, Moses L. Najjuka, Christine F. Springerplus Research BACKGROUND: Multidrug resistant Pseudomonas aeruginosa and Acinetobacter baumannii are common causes of health care associated infections worldwide. Carbapenems are effective against infections caused by multidrug resistant Gram-negative bacteria including Pseudomonas and Acinetobacter species. However, their use is threatened by the emergence of carbapenemase-producing strains. The aim of this study was to determine the prevalence of carbapenem-resistant P. aeruginosa and A. baumannii at Mulago Hospital in Kampala Uganda, and to establish whether the hospital environment harbors carbapenem-resistant Gram-negative rods. RESULTS: Between February 2007 and September 2009, a total of 869 clinical specimens were processed for culture and sensitivity testing yielding 42 (5 %) P. aeruginosa and 29 (3 %) A. baumannii isolates, of which 24 % (10/42) P. aeruginosa and 31 % (9/29) A. baumannii were carbapenem-resistant. Additionally, 80 samples from the hospital environment were randomly collected and similarly processed yielding 58 % (46/80) P. aeruginosa and 14 % (11/80) A. baumannii, of which 33 % (15/46) P. aeruginosa and 55 % (6/11) A. baumannii were carbapenem-resistant. The total number of isolates studied was 128. Carbapenemase genes detected were bla(IMP)-like (36 %, 9/25), bla(VIM)-like (32 %, 8/25), bla(SPM)-like (16 %, 4/25); bla(NDM-1)-like (4 %, 1/25) in carbapenem-resistant P. aeruginosa, and bla(OXA-23)-like (60 %, 9/15), bla(OXA-24)-like (7 %, 1/15), bla(OXA-58)-like (13 %, 2/15), and bla(VIM)-like (13 %, 2/15) in carbapenem-resistant A. baumannii. Furthermore, class 1 integrons were detected in 38 % (48/128) of P. aeruginosa and Acinetobacter, 37 % (26/71) of which were in clinical isolates and 39 % (22/57) in environment isolates. Gene cassettes were found in 25 % (12/48) of integron-positive isolates. These were aminoglycoside adenylyltransferase ant(4′)-IIb (3 isolates); trimethoprim-resistant dihydrofolate reductase dfrA (2 isolates); adenyltransferase aadAB (3 isolates); QacE delta1 multidrug exporter (2 isolates); quinolone resistance pentapeptide repeat protein qnr (1 isolate); and metallo-β-lactamase genes bla(VIM-4)-like, bla(IMP-19)-like, and bla(IMP-26)-like (1 isolate each). Gene cassettes were missing in 75 % (36/48) of the integron-positive isolates. CONCLUSIONS: The prevalence of carbapenem-resistant P. aeruginosa and Acinetobacter among hospitalized patients at Mulago Hospital is low compared to rates from South-East Asia. However, it is high among isolates and in the environment, which is of concern given that the hospital environment is a potential source of infection for hospitalized patients and health care workers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40064-016-2986-7) contains supplementary material, which is available to authorized users. Springer International Publishing 2016-08-09 /pmc/articles/PMC4978656/ /pubmed/27547682 http://dx.doi.org/10.1186/s40064-016-2986-7 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Kateete, David P. Nakanjako, Ritah Namugenyi, Juliet Erume, Joseph Joloba, Moses L. Najjuka, Christine F. Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009) |
title | Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009) |
title_full | Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009) |
title_fullStr | Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009) |
title_full_unstemmed | Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009) |
title_short | Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009) |
title_sort | carbapenem resistant pseudomonas aeruginosa and acinetobacter baumannii at mulago hospital in kampala, uganda (2007–2009) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978656/ https://www.ncbi.nlm.nih.gov/pubmed/27547682 http://dx.doi.org/10.1186/s40064-016-2986-7 |
work_keys_str_mv | AT kateetedavidp carbapenemresistantpseudomonasaeruginosaandacinetobacterbaumanniiatmulagohospitalinkampalauganda20072009 AT nakanjakoritah carbapenemresistantpseudomonasaeruginosaandacinetobacterbaumanniiatmulagohospitalinkampalauganda20072009 AT namugenyijuliet carbapenemresistantpseudomonasaeruginosaandacinetobacterbaumanniiatmulagohospitalinkampalauganda20072009 AT erumejoseph carbapenemresistantpseudomonasaeruginosaandacinetobacterbaumanniiatmulagohospitalinkampalauganda20072009 AT jolobamosesl carbapenemresistantpseudomonasaeruginosaandacinetobacterbaumanniiatmulagohospitalinkampalauganda20072009 AT najjukachristinef carbapenemresistantpseudomonasaeruginosaandacinetobacterbaumanniiatmulagohospitalinkampalauganda20072009 |